Comprehensive Postpartum Depression Market Forecast 2025-2034: Growth Trends and Strategic Shifts

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts

Postpartum Depression Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for postpartum depression has experienced substantial growth in recent past. The projections indicate an increase from $12.15 billion in 2024 to $16.09 billion in 2025, signifying a compound annual growth rate (CAGR) of 32.4%. Factors behind the historical period growth include awareness about maternal mental health, developments in research, public health campaigns, and heightened screening measures.

Postpartum Depression Market Size Forecast: What's the Projected Valuation by 2029?
In the coming years, the market size for postpartum depression is projected to expand dramatically. It is anticipated to escalate to $49.4 billion in 2029, growing at a compound annual growth rate (CAGR) of 32.4%. Factors such as telehealth facilities, advancements in pharmacology, laws governing maternal mental health, and an increase in mental health workforce can be credited for the projected growth within this period. The period is also expected to witness dominant trends such as the introduction of consolidated care models, peer assistance initiatives, mental health applications for perinatal period, and mental health evaluation instruments.

View the full report here:
https://www.thebusinessresearchcompany.com/report/postpartum-depression-global-market-report

What Are the Drivers Transforming the Postpartum Depression Market?
The projection of an increase in postpartum depression occurrences is anticipated to stimulate the expansion of the postpartum depression market. Postpartum depression arises from an excessive concern that sets in after childbirth, often accompanied by physical symptoms. This form of depression often goes hand in hand with postnatal depression and postpartum anxiety, with symptoms unpredictably manifesting anytime within the first year after childbirth. Treatment usually involves psychotherapy - also known as talk therapy or mental health counselling - medication, or a combo of both, hence fostering market growth. To illustrate, a February 2022 survey by the University of Virginia School of Medicine (UVA SoM) involving 1.1 million mothers pinpointed that postpartum depression risk is at its peak among first-time mothers, those aged under 25, and mothers of twins. Women aged 18-24 had the highest self-reported rate of postpartum depression symptoms at 10%. Mothers of twins had a higher rate of postpartum depression, with 11.3% exhibiting symptoms compared to 8.3% of mothers with single babies. This escalation in postpartum depression cases is set to catalyze the postpartum depression market. An increase in the number of childbirths is believed to be a key driver in the expansion of the postpartum depression market. Childbirth, the process through which a baby is born from a mother's uterus, typically occurs through the vaginal canal. The growing number of childbirths plays a significant role in the postpartum depression market, given that postpartum depression (PPD) is a typical mental health issue affecting women after they give birth. It can lead to a multitude of symptoms, including sadness, anxiety, fatigue, and problems bonding with the baby. For instance, a report by the Centers for Disease Control and Prevention in January 2023 highlighted a 1% increase in recorded births in the United States, with a total of 3,664,292 compared to the prior year. Therefore, the increase in childbirth rates is fueling the growth of the postpartum depression market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13024&type=smp

What Long-Term Trends Will Define the Future of the Postpartum Depression Market?
Companies in the postpartum depression sector are developing new product advancements to maintain their market status. The scarcity of treatment options has instigated an increased need for more innovative, quick-acting treatments and imaginative care provisions for postpartum depression. For example, the United States Food and Drug Administration (FDA) accepted a new drug application for zuranolone, from US-based biotech firm Biogen Inc., and US-based bio pharmaceutical company, Sage Therapeutics Inc., in February 2023. Zuranolone, an experimental drug being evaluated as a 14-day, once a day, fast-acting oral treatment for people suffering from major depressive disorder (MDD) and postpartum depression (PPD), is a neuroactive steroid that serves as a active allosteric modulator of the GABA-A receptors. This unique mechanism of action supposedly works by rapidly resetting unbalanced neural networks to aid in restoring brain function in individuals with depression. Zuranolone has an effect on brain networks regulating mood, arousal, behavior and even cognition.

Which Segments in the Postpartum Depression Market Offer the Most Profit Potential?
The postpartum depression market covered in this report is segmented -

1) By Types: Postpartum Blues, Postpartum Anxiety, Postpartum Obsessive Compulsive Disorder, Postpartum Panic Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Psychosis, Other Types
2) By Treatment: Psychotherapy, Medication, Supplements, Other Treatments
3) By Route of Administration: Oral, Parenteral, Other Route Of Administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:
1) By Postpartum Blues: Mild Emotional Disturbances, Short-term Mood Swings
2) By Postpartum Anxiety: Generalized Anxiety Disorder (GAD), Panic Attacks
3) By Postpartum Obsessive Compulsive Disorder: Intrusive Thoughts, Compulsive Behaviors
4) By Postpartum Panic Disorder: Sudden Panic Attacks, Physical Symptoms
5) By Postpartum Post-Traumatic Stress Disorder (PTSD): Trauma Response To Childbirth, Flashbacks And Anxiety
6) By Postpartum Psychosis: Hallucinations, Severe Mood Swings
7) By Other Types: Mixed Mood Disorders, Comorbid Conditions With Postpartum

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13024&type=smp

Which Firms Dominate the Postpartum Depression Market by Market Share and Revenue in 2025?
Major companies operating in the postpartum depression market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co., AbbVie Inc., Novartis AG, Sanofi SA, Bristol Myers Squibb Co., AstraZeneca PLC, GlaxoSmithKline LLC, Takeda Pharmaceutical Company, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Viatris Inc., Northwell Health, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Lupin Pharmaceuticals, Mallinckrodt Pharmaceuticals PLC, Sage Therapeutics Inc.

Which Regions Offer the Highest Growth Potential in the Postpartum Depression Market?
North America was the largest region in the postpartum depression market in 2024. The regions covered in postpartum depression market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13024

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.